From what I remember, ATH has had earlier a patent for PBT2 in cardiac light chain amyloidosis, it is usually mentioned in the annual report. Now, if I understand this correctly, the new patent is for "immunoglobulin light chain amyloidosis" and cardiac light chain amyloidosis is only a part of this. I post here a brand new about light chain amyloidosis. The only PBT2 paper in this field is this: Cardiac Light Chain Amyloidosis: The Role of Metal Ions in Oxidative Stress and Mitochondrial Damage - PubMed (nih.gov). It was done with an Italian group and Dr. Robert Cherny from Prana.
Here you can find the review if you are interested in light-chain amyloidosis: IJMS | Free Full-Text | Molecular Mechanism of Pathogenesis and Treatment Strategies for AL Amyloidosis | HTML (mdpi.com).
It is interesting that there are no scientific papers published about this. We do not know if the drug is PBT2 or ATH434, both are metal chelators. i would think that the drug is PBT2, but it could be also ATH434 or another metal chelator.
- Forums
- ASX - By Stock
- Ann: Alterity to present at GCFF Virtual Conference 2022
From what I remember, ATH has had earlier a patent for PBT2 in...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.3¢ | $2.733K | 832.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 45274833 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 126718541 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 44856500 | 0.003 |
62 | 92776603 | 0.002 |
28 | 123111099 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 126718541 | 16 |
0.005 | 26858632 | 28 |
0.006 | 15243927 | 24 |
0.007 | 55868969 | 31 |
0.008 | 23800417 | 27 |
Last trade - 15.57pm 09/08/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |